4//SEC Filing
Kennedy Eugene P. 4
Accession 0000899243-22-030285
CIK 0001563577other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:15 PM ET
Size
5.4 KB
Accession
0000899243-22-030285
Insider Transaction Report
Form 4
Kennedy Eugene P.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-01+150,000→ 150,000 totalExercise: $1.29Exp: 2032-08-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% on September 1, 2023, and in thirty-six (36) substantially equal monthly installments over a three-year period thereafter.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001721685
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:15 PM ET
- Size
- 5.4 KB